Xalkori
Xalkori | |
---|---|
Term | Xalkori |
Short definition | Xalkori - (pronounced) (zal-KOR-ee) A drug used to treat certain types of ALK-positive inflammatory myofibroblastic tumors in adults and children 1 year and older, ALK-positive systemic anaplastic large cell lymphoma in young adults and children 1 year and older, and ALK-positive or ROS1-positive non-small cell lung cancer. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Xalkori - (pronounced) (zal-KOR-ee) A drug used to treat certain types of ALK-positive inflammatory myofibroblastic tumors in adults and children 1 year and older, ALK-positive systemic anaplastic large cell lymphoma in young adults and children 1 year and older, and ALK-positive or ROS1-positive non-small cell lung cancer. It is also being studied in the treatment of other types of cancer. Xalkori blocks certain proteins made by the ALK and ROS1 genes, which may help prevent cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also called crizotinib
External links
- Medical encyclopedia article on Xalkori
- Wikipedia's article - Xalkori
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski